Artykuły w czasopismach na temat „WISP3”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „WISP3”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Kutz, Wendy E., Yaoqin Gong, and Matthew L. Warman. "WISP3, the Gene Responsible for the Human Skeletal Disease Progressive Pseudorheumatoid Dysplasia, Is Not Essential for Skeletal Function in Mice." Molecular and Cellular Biology 25, no. 1 (2005): 414–21. http://dx.doi.org/10.1128/mcb.25.1.414-421.2005.
Pełny tekst źródłaPojskic, Lejla, Ismet Gavrankapetanovic, Naida Lojo-Kadric, Rifat Hadziselimovic, and Kasim Bajrovic. "A genotyping assay for missense mutation in WISP3 gene associated with childhood onset pseudorheumatoid arthropathy." Journal of Health Sciences 5, no. 2 (2015): 59–64. http://dx.doi.org/10.17532/jhsci.2015.241.
Pełny tekst źródłaWu, Qunfeng, Marda Jorgensen, Joanna Song, Junmei Zhou, Chen Liu, and Liya Pi. "Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma." Gastroenterology Research and Practice 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/2313850.
Pełny tekst źródłaRepudi, S. R., M. Patra, and M. Sen. "WISP3-IGF1 interaction regulates chondrocyte hypertrophy." Journal of Cell Science 126, no. 7 (2013): 1650–58. http://dx.doi.org/10.1242/jcs.119859.
Pełny tekst źródłaLeask, Andrew. "CCN6 (WISP3): a new anti-cancer therapy?" Journal of Cell Communication and Signaling 4, no. 4 (2010): 199–200. http://dx.doi.org/10.1007/s12079-010-0106-y.
Pełny tekst źródłaYi, Yang, Jun Ma, Lu Jianrao, Hangqing Wang, and Yingdan Zhao. "WISP3 prevents fibroblast–myofibroblast transdifferentiation in NRK-49F cells." Biomedicine & Pharmacotherapy 99 (March 2018): 306–12. http://dx.doi.org/10.1016/j.biopha.2018.01.005.
Pełny tekst źródłaCui, Rong-Rong, Jiao Huang, Lu Yi, et al. "WISP3 suppresses insulin-like growth factor signaling in human chondrocytes." Molecular and Cellular Endocrinology 279, no. 1-2 (2007): 1–8. http://dx.doi.org/10.1016/j.mce.2007.08.007.
Pełny tekst źródłaBhavani, Gandham SriLakshmi, Hitesh Shah, Ashwin B. Dalal, et al. "Novel and recurrent mutations in WISP3 and an atypical phenotype." American Journal of Medical Genetics Part A 167, no. 10 (2015): 2481–84. http://dx.doi.org/10.1002/ajmg.a.37164.
Pełny tekst źródłaMahadevan, S., B. Navaneethan, N. Gopalakrishnapillai Syamala, M. Mamadapur, R. S, and T. Tn. "AB0779 CAN INFLAMMATION COEXIST IN PATIENTS WITH PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA?" Annals of the Rheumatic Diseases 80, Suppl 1 (2021): 1415.4–1416. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3480.
Pełny tekst źródłaUlutaş, Alptekin, Dragiša Stanujkić, Darjan Karabašević, Gabrijela Popović, and Srđan Novaković. "Pallet truck selection with MEREC and WISP-S methods." Strategic Management, no. 00 (2022): 13. http://dx.doi.org/10.5937/straman2200013u.
Pełny tekst źródłaKleer, Celina G., Yanhong Zhang, Quintin Pan, et al. "WISP3 is a novel tumor suppressor gene of inflammatory breast cancer." Oncogene 21, no. 20 (2002): 3172–80. http://dx.doi.org/10.1038/sj.onc.1205462.
Pełny tekst źródłaTran, Mai N., and Celina G. Kleer. "Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas." Journal of Cell Communication and Signaling 12, no. 1 (2018): 13–19. http://dx.doi.org/10.1007/s12079-018-0451-9.
Pełny tekst źródłaHashimoto, Yasunobu. "Effect of Wnt signaling protein (Wisp2/CCN5) on angiogenesis and invasion in prostate cancer." Journal of Clinical Oncology 30, no. 5_suppl (2012): 227. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.227.
Pełny tekst źródłaHashimoto, Yasunobu, Rajendra Singh, and Bal L. Lokeshwar. "Effect of Wnt-1 induced signaling protein-2 (Wisp-2/CCN5) on angiogenesis and invasion in prostate cancer." Journal of Clinical Oncology 31, no. 6_suppl (2013): 164. http://dx.doi.org/10.1200/jco.2013.31.6_suppl.164.
Pełny tekst źródłaHurvitz, Jennifer R., Wafaa M. Suwairi, Wim Van Hul, et al. "Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia." Nature Genetics 23, no. 1 (1999): 94–98. http://dx.doi.org/10.1038/12699.
Pełny tekst źródłaSen, Malini, Yu-Ho Cheng, Mary B. Goldring, Martin K. Lotz, and Dennis A. Carson. "WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes." Arthritis & Rheumatism 50, no. 2 (2004): 488–97. http://dx.doi.org/10.1002/art.20005.
Pełny tekst źródłaRobotham, A. S. G., J. C. J. D’Silva, R. A. Windhorst, et al. "Dynamic Wisp Removal in JWST NIRCam Images." Publications of the Astronomical Society of the Pacific 135, no. 1050 (2023): 085003. http://dx.doi.org/10.1088/1538-3873/acea42.
Pełny tekst źródłaChowdhury, Md Faizul Islam, Shamima Sharmin Shova, Afia Zahin Monami, Rajibul Alam, and M. Ekhlasur Rahman. "Progressive pseudo-rheumatoid dysplasia -a rare genetic disorder: Case Report." Anwer Khan Modern Medical College Journal 13, no. 1 (2021): 52–55. http://dx.doi.org/10.3329/akmmcj.v13i1.64730.
Pełny tekst źródłaYu, Xiaofu, Ruoying Mao, Wei Feng, et al. "WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade." Experimental Cell Research 409, no. 1 (2021): 112871. http://dx.doi.org/10.1016/j.yexcr.2021.112871.
Pełny tekst źródłaHuang, Wei, Emily E. Martin, Boris Burman, Maria E. Gonzalez, and Celina G. Kleer. "The matricellular protein CCN6 (WISP3) decreases Notch1 and suppresses breast cancer initiating cells." Oncotarget 7, no. 18 (2016): 25180–93. http://dx.doi.org/10.18632/oncotarget.7734.
Pełny tekst źródłaKleer, Celina G., Yanhong Zhang, and Sofia D. Merajver. "CCN6 (WISP3) as a New Regulator of the Epithelial Phenotype in Breast Cancer." Cells Tissues Organs 185, no. 1-3 (2007): 95–99. http://dx.doi.org/10.1159/000101308.
Pełny tekst źródłaNakamura, Yukio, Yajun Cui, Carol Fernando, Wendy E. Kutz, and Matthew L. Warman. "Normal growth and development in mice over-expressing the CCN family member WISP3." Journal of Cell Communication and Signaling 3, no. 2 (2009): 105–13. http://dx.doi.org/10.1007/s12079-009-0040-z.
Pełny tekst źródłaLuo, Haiyang, Changhe Shi, Chengyuan Mao, et al. "A novel compound WISP3 mutation in a Chinese family with progressive pseudorheumatoid dysplasia." Gene 564, no. 1 (2015): 35–38. http://dx.doi.org/10.1016/j.gene.2015.03.029.
Pełny tekst źródłaTanaka, Shinji, Keishi Sugimachi, Shin-Ichiro Maehara, Mitsuo Shimada, and Yoshihiko Maehara. "A loss of function mutation in WISP3 derived from microsatellite unstable gastric carcinoma." Gastroenterology 125, no. 5 (2003): 1563–64. http://dx.doi.org/10.1016/j.gastro.2003.04.013.
Pełny tekst źródłaPatel, Chandreshkumar, Anas M. Khanshour, David Wilkes, et al. "Novel homozygous variant in WISP3 in a family with unrecognized progressive pseudorheumatoid dysplasia." Clinical Case Reports 8, no. 8 (2020): 1452–57. http://dx.doi.org/10.1002/ccr3.2884.
Pełny tekst źródłaMiller, Dustyn S., and Malini Sen. "Potential role of WISP3 (CCN6) in regulating the accumulation of reactive oxygen species." Biochemical and Biophysical Research Communications 355, no. 1 (2007): 156–61. http://dx.doi.org/10.1016/j.bbrc.2007.01.114.
Pełny tekst źródłaOutrequin, Antoine, Julie Manon, Amaury Paulmier, Dan Putineanu, Pierre-Louis Docquier, and Olivier Cornu. "Multiple Joint Replacements for Progressive Pseudorheumatoid Dysplasia: A Case Report." Journal of Orthopaedic Case Reports 14, no. 4 (2024): 18–23. http://dx.doi.org/10.13107/jocr.2024.v14.i04.4344.
Pełny tekst źródłaSchütze, Norbert, Rita Schenk, Jörg Fiedler, Thomas Mattes, Franz Jakob, and Rolf E. Brenner. "CYR61/CCN1 and WISP3/CCN6 are chemoattractive ligands for human multipotent mesenchymal stroma cells." BMC Cell Biology 8, no. 1 (2007): 45. http://dx.doi.org/10.1186/1471-2121-8-45.
Pełny tekst źródłaSun, Jing, Weibo Xia, Shuli He, et al. "Novel and Recurrent Mutations of WISP3 in Two Chinese Families with Progressive Pseudorheumatoid Dysplasia." PLoS ONE 7, no. 6 (2012): e38643. http://dx.doi.org/10.1371/journal.pone.0038643.
Pełny tekst źródłaLee, Ju Hwa, Youn Jin Choi, Eun Mi Je, Ho Shik Kim, Nam Jin Yoo, and Sug Hyung Lee. "Frameshift mutation of WISP3 gene and its regional heterogeneity in gastric and colorectal cancers." Human Pathology 50 (April 2016): 146–52. http://dx.doi.org/10.1016/j.humpath.2015.12.009.
Pełny tekst źródłaSong, Dandan, Liang Wang, Ke Su, Huanhuan Wu та Junli Li. "WISP1 aggravates cell metastatic potential by abrogating TGF-β-Smad2/3-dependent epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma". Experimental Biology and Medicine 246, № 11 (2021): 1244–52. http://dx.doi.org/10.1177/1535370221992703.
Pełny tekst źródłaBabenko, L. I. "ON THE MANUFACTURE TECHNIQUE OF PSEUDO-TWISTED WISPS OF THE PECTORAL FROM THE TOVSTA MOHYLA BARROW." Archaeology and Early History of Ukraine 42, no. 1 (2022): 19–32. http://dx.doi.org/10.37445/adiu.2022.01.01.
Pełny tekst źródłaNakamura, Yukio, Gilbert Weidinger, Jennifer O. Liang, et al. "The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling." Journal of Clinical Investigation 117, no. 10 (2007): 3075–86. http://dx.doi.org/10.1172/jci32001.
Pełny tekst źródłaLiu, Limin, Nan Li, Zhen Zhao, Wei Li, and Weibo Xia. "Novel WISP3 mutations causing spondyloepiphyseal dysplasia tarda with progressive arthropathy in two unrelated Chinese families." Joint Bone Spine 82, no. 2 (2015): 125–28. http://dx.doi.org/10.1016/j.jbspin.2014.10.005.
Pełny tekst źródłaRiaz, Maira, Zubair Khoso, Versha Rani Rai, Misbah Iqbal Hanif, Mohsina Noor Ibrahim, and Syed Jamal Raza. "A RARE SKELETAL DYSPLASIA-CLOSE MIMICKER OF JUVENILE IDIOPATHIC ARTHRITIS-PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA." Journal of Ayub Medical College Abbottabad 34, no. 4(SUPPL 1) (2022): 1050–52. http://dx.doi.org/10.55519/jamc-04-s4-10897.
Pełny tekst źródłaKleer, Celina G., Yanhong Zhang, Quintin Pant, and Sofia D. Merajver. "WISP3 (CCN6) Is a Secreted Tumor-Suppressor Protein that Modulates IGF Signaling in Inflammatory Breast Cancer." Neoplasia 6, no. 2 (2004): 179–85. http://dx.doi.org/10.1593/neo.03316.
Pełny tekst źródłaYU, YAFEN, MAN HU, XUESHA XING, et al. "Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia." Molecular Medicine Reports 12, no. 1 (2012): 419–25. http://dx.doi.org/10.3892/mmr.2015.3430.
Pełny tekst źródłaGao, Hong, Fen‐Fen Yin, Dong‐Xian Guan та ін. "Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β‐catenin/TCF/LEF signalling". Cell Proliferation 52, № 3 (2019): e12583. http://dx.doi.org/10.1111/cpr.12583.
Pełny tekst źródłaYue, Hua, Zhen-Lin Zhang, and Jin-Wei He. "Identification of novel mutations in WISP3 gene in two unrelated Chinese families with progressive pseudorheumatoid dysplasia." Bone 44, no. 4 (2009): 547–54. http://dx.doi.org/10.1016/j.bone.2008.11.005.
Pełny tekst źródłaHann, Steven, Laura Kvenvold, Brittney N. Newby, Minh Hong, and Matthew L. Warman. "A Wisp3 Cre-knockin Allele Produces Efficient Recombination in Spermatocytes during Early Prophase of Meiosis I." PLoS ONE 8, no. 9 (2013): e75116. http://dx.doi.org/10.1371/journal.pone.0075116.
Pełny tekst źródłaChouery, Eliane, Sandra Corbani, Jaleleddine Dahmen, et al. "Progressive pseudorheumatoid dysplasia in North and West Africa: Clinical description in ten patients with mutations of WISP3." Egyptian Journal of Medical Human Genetics 18, no. 3 (2017): 299–303. http://dx.doi.org/10.1016/j.ejmhg.2016.11.004.
Pełny tekst źródłaZhou, Hou-De, Yan-Hong Bu, Hui Xie, Yi-Qun Peng, Min Wan, and Er-Yuan Liao. "Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation." Bone 43 (October 2008): S48. http://dx.doi.org/10.1016/j.bone.2008.08.030.
Pełny tekst źródłaZhou, Hou-De, Yan-Hong Bu, Yi-Qun Peng, et al. "Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation." Journal of Molecular Medicine 85, no. 9 (2007): 985–96. http://dx.doi.org/10.1007/s00109-007-0193-2.
Pełny tekst źródłaPaciejewska, Maja Maria, Marijke Maijenburg, Christian Gilissen, et al. "Differential Effects of Wnt Signaling on Proliferation and Hematopoietic Support of Adult and Fetal Bone Marrow-Derived MSCs." Blood 124, no. 21 (2014): 5137. http://dx.doi.org/10.1182/blood.v124.21.5137.5137.
Pełny tekst źródłaLorenzatti, G., W. Huang, A. Pal, A. M. Cabanillas, and C. G. Kleer. "CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer." Journal of Cell Science 124, no. 10 (2011): 1752–58. http://dx.doi.org/10.1242/jcs.084194.
Pełny tekst źródłaHuang, Wei, Maria E. Gonzalez, Kathy A. Toy, Mousumi Banerjee, and Celina G. Kleer. "Blockade of CCN6 (WISP3) Activates Growth Factor–Independent Survival and Resistance to Anoikis in Human Mammary Epithelial Cells." Cancer Research 70, no. 8 (2010): 3340–50. http://dx.doi.org/10.1158/0008-5472.can-09-4225.
Pełny tekst źródłaJiang, Nan, Yu Wang, Zhiqiang Yu, et al. "WISP3 (CCN6) Regulates Milk Protein Synthesis and Cell Growth Through mTOR Signaling in Dairy Cow Mammary Epithelial Cells." DNA and Cell Biology 34, no. 8 (2015): 524–33. http://dx.doi.org/10.1089/dna.2015.2829.
Pełny tekst źródłaBarcus, Craig E., and Gregory D. Longmore. "Collagen Linearization within Tumors." Cancer Research 81, no. 22 (2021): 5611–12. http://dx.doi.org/10.1158/0008-5472.can-21-2939.
Pełny tekst źródłaStinebring, D. R., K. M. Becker, J. E. Espinoza Goodman, et al. "A (new) Phenomenon in Pulsar Dynamic Spectra." International Astronomical Union Colloquium 177 (2000): 559–60. http://dx.doi.org/10.1017/s0252921100060619.
Pełny tekst źródłaBatsali, Aristea, Charalampos Pontikoglou, Emmanuel Agrafiotis, et al. "Emerging Roles of Wisp-1 and SFRP4 in Proliferation and Differentiation Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells." Blood 124, no. 21 (2014): 4375. http://dx.doi.org/10.1182/blood.v124.21.4375.4375.
Pełny tekst źródła